60 Degrees Pharmaceuticals (SXTPW) Competitors $0.11 0.00 (0.00%) As of 08/21/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock SXTPW vs. ATNFW, DRTSW, APLMW, BCTXW, CDIOW, CELUW, CEROW, CINGW, CLNNW, and COEPWShould you be buying 60 Degrees Pharmaceuticals stock or one of its competitors? The main competitors of 60 Degrees Pharmaceuticals include 180 Life Sciences (ATNFW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Celularity (CELUW), CERo Therapeutics (CEROW), Cingulate (CINGW), Clene (CLNNW), and Coeptis Therapeutics (COEPW). These companies are all part of the "biotechnology" industry. 60 Degrees Pharmaceuticals vs. Its Competitors 180 Life Sciences Alpha Tau Medical Apollomics BriaCell Therapeutics Cardio Diagnostics Celularity CERo Therapeutics Cingulate Clene Coeptis Therapeutics 180 Life Sciences (NASDAQ:ATNFW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, analyst recommendations, media sentiment, dividends and institutional ownership. Which has preferable valuation and earnings, ATNFW or SXTPW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/A60 Degrees Pharmaceuticals$641.41KN/AN/AN/AN/A Is ATNFW or SXTPW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A 60 Degrees Pharmaceuticals N/A N/A N/A Does the media prefer ATNFW or SXTPW? In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for 60 Degrees Pharmaceuticals and 0 mentions for 180 Life Sciences. 60 Degrees Pharmaceuticals' average media sentiment score of 1.97 beat 180 Life Sciences' score of 1.14 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment 180 Life Sciences Positive 60 Degrees Pharmaceuticals Very Positive Summary60 Degrees Pharmaceuticals beats 180 Life Sciences on 3 of the 3 factors compared between the two stocks. Get 60 Degrees Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTPW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SXTPW vs. The Competition Export to ExcelMetric60 Degrees PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$137.09M$5.76B$9.58BDividend YieldN/A3.74%4.41%4.10%P/E RatioN/A3.8731.1026.04Price / SalesN/A4,057.33435.26103.29Price / CashN/A13.1937.7358.48Price / BookN/A46.309.536.61Net IncomeN/A-$90.99M$3.26B$265.56M7 Day Performance0.09%0.42%2.10%1.95%1 Month PerformanceN/A3.51%2.82%-0.37%1 Year PerformanceN/A205.46%30.56%19.02% 60 Degrees Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SXTPW60 Degrees PharmaceuticalsN/A$0.11flatN/A+82.2%$0.00$641.41K0.002Positive NewsATNFW180 Life SciencesN/A$0.38+256.8%N/A+2,413.2%$0.00N/A0.007Positive NewsGap DownHigh Trading VolumeDRTSWAlpha Tau MedicalN/A$0.27+3.8%N/A+49.5%$0.00N/A0.0080APLMWApollomicsN/A$0.03+17.6%N/A+26.3%$0.00N/A0.0059Positive NewsBCTXWBriaCell TherapeuticsN/A$0.02-10.8%N/A-90.7%$0.00N/A0.008Positive NewsGap DownHigh Trading VolumeCDIOWCardio DiagnosticsN/A$0.01-0.7%N/A-51.7%$0.00$19.90K0.007Positive NewsShort Interest ↓Gap DownCELUWCelularityN/A$0.05+1.1%N/A+145.0%$0.00$54.22M0.00220Positive NewsCEROWCERo TherapeuticsN/A$0.02+19.4%N/A-28.4%$0.00N/A0.008Positive NewsGap DownCINGWCingulateN/A$0.07-6.3%N/A-41.7%$0.00N/A0.0020Positive NewsGap DownCLNNWCleneN/A$0.03+0.4%N/AN/A$0.00$350K0.00100Positive NewsGap UpCOEPWCoeptis TherapeuticsN/A$0.02flatN/A+52.2%$0.00$62.87K0.004Positive NewsGap Down Related Companies and Tools Related Companies ATNFW Alternatives DRTSW Alternatives APLMW Alternatives BCTXW Alternatives CDIOW Alternatives CELUW Alternatives CEROW Alternatives CINGW Alternatives CLNNW Alternatives COEPW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SXTPW) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 60 Degrees Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 60 Degrees Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access